Cetyltrimethylammonium Bromide Disrupts the Mesenchymal Characteristics of HA22T/VGH Cells<i>Via</i>Inactivation of c-Met/PI3K/Akt/mTOR PathwayChia-Herng Yue, CHIA-JEN LEE|Anticancer Research|2020Cited by 5
Cetyltrimethylammonium Bromide Suppresses the Migration and Invasion of Hepatic Mahlavu Cells by Modulating Fibroblast Growth Factor SignalingTsai‐Kun Wu, CHIA-JEN LEE|Anticancer Research|2020Cited by 4
Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling PathwayTsai‐Kun Wu, CHIA-JEN LEE|Anticancer Research|2021Cited by 4
Cetyltrimethylammonium Bromide Disrupts Mesenchymal Characteristics of Human Tongue Squamous Cell Carcinoma SCC4 Cells Through Modulating Canonical TGF-β/Smad/miR-181b/TIMP3 Signaling PathwayChia-Herng Yue, CHIA-JEN LEE|Anticancer Research|2021Cited by 4